The purpose of this research is to find out if the study drug, EIDD-2801, can help people recover from coronavirus disease 2019 (COVID-19), as well as limit the spread of COVID-19 between people. EIDD-2801 is an experimental treatment not approved by the U.S. Food and Drug Administration (FDA).
Thank you for your interest, but this study is not currently enrolling.
North Carolina (Alamance, Chatham, Durham, Franklin, Granville, Harnett, Johnston, Lee, Nash, Orange, Wake, Wilson)
Clinical or Medical